Clinical Trial Results

Showing: All studies [change]
Condition: Obesity Location: Rhode Island 25 trials found
New Search
Filter
Trial Phase
Study Type
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
PHASE3INTERVENTIONAL Alexander City, Alabama +4 more
RECRUITING
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
PHASE3INTERVENTIONAL Daphne, Alabama +4 more
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
PHASE3INTERVENTIONAL Northridge, California +4 more
RECRUITING
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
PHASE3INTERVENTIONAL Northridge, California +4 more
RECRUITING
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
PHASE3INTERVENTIONAL Daphne, Alabama +4 more
RECRUITING
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
PHASE3INTERVENTIONAL Glendale, Arizona +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Tuscaloosa, Alabama +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults
PHASE1INTERVENTIONAL Bayswater, Victoria
RECRUITING
A Study to Evaluate MWN109 Tablets in Healthy Adult Participants
PHASE1INTERVENTIONAL Adelaide, South Australia +1 more
RECRUITING
A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight Adults
PHASE1INTERVENTIONAL Bayswater, Victoria
RECRUITING
Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes
PHASE2INTERVENTIONAL Bayswater, Victoria
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
An Early Phase Study of RT-114 (RaniPill Containing PG-102, a GLP-1/2 Dual Agonist) in Healthy Volunteers.
PHASE1INTERVENTIONAL Melbourne, Victoria
RECRUITING
Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
PHASE4INTERVENTIONAL Fitzroy, Victoria +3 more
RECRUITING
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
The Bariatric Surgery Registry
N/AOBSERVATIONAL Melbourne, Victoria
RECRUITING
A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight
PHASE1INTERVENTIONAL Melbourne
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type